Association with <scp>HLA‐DRB1</scp> in Egyptian and German pemphigus vulgaris patients
Ozan Haase(University of Lübeck), Saleh Ibrahim(Khalifa University of Science and Technology), S. Al Mongy(Mansoura University), Rüdiger Eming(Philipps University of Marburg), Michael Hertl(Universitätsklinikum Gießen und Marburg), R. Alneebari(Institute for Integrative and Experimental Genomics), Fatma Y. A. Abbas(Mansoura University), Enno Schmidt(Carrier (United States)), EmanA El-Nabarawy(Cairo University), Dina Dorgham(Cairo University), Steffen Möller(University of Rostock), Detlef Zillikens(University of Lübeck), Youssef M. Mosaad(Mansoura University), H. Mosaad El Sayed(Mansoura University), Azza M. Abd-Elaziz(Mansoura University), S. B. El Din Mahmoud(Cairo University), Mohamed El‐Darouti(Cairo University), M. Abd El Hady(Cairo University), Farha El‐Chennawi(Mansoura University), S. Abd El Gaber(Mansoura University), Mohamed Darwish(Mansoura University), Shereen Salah(Mansoura University), Andreas Recke(University of Lübeck)
Cited by 17
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies
|Journal of Investigative Dermatology|1997|309